What Market will look at is Neuren's sole product is in hands with the company going downhill. If that is the case how will Accadia continue to meet its royalty payment obligation to Neuren. There is so much negativity at the moment for Neu: short sellers report, Daybue peaked sales and now partnered company losing grip. All uncertainty and market hates uncertainty.
What Market will look at is Neuren's sole product is in...
-
- There are more pages in this discussion • 490 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.33 |
Change
-0.480(3.48%) |
Mkt cap ! $1.703B | |||
| Open | High | Low | Value | Volume |
| $13.82 | $13.91 | $13.32 | $4.989M | 369.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.41 | 1680 | 2 |
View Market Depth
| Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |